Friess Associates’s CryoPort CYRX Stock Holding History

Friess Associates’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-105,044	Closed	-$6.21M	–	99
2021 Q4	$6.21M	Sell	105,044 -5,954	-5%	-$412K	2.43%	5
2021 Q3	$7.38M	Sell	110,998 -8,658	-7%	-$534K	3.11%	3
2021 Q2	$7.55M	Buy	119,656 +16,013	+15%	+$901K	2.85%	7
2021 Q1	$5.39M	Buy	103,643 +23,743	+30%	+$1.44M	2.1%	12
2020 Q4	$3.51M	Sell	79,900 -30,788	-28%	-$1.47M	0.26%	67
2020 Q3	$5.25M	Sell	110,688 -52,300	-32%	-$2.12M	0.45%	55
2020 Q2	$4.93M	Sell	162,988 -116,918	-42%	-$2.6M	0.46%	57
2020 Q1	$4.78M	Sell	279,906 -38,178	-12%	-$669K	0.48%	61
2019 Q4	$5.24M	Buy	318,084 +84,379	+36%	+$1.26M	0.36%	76
2019 Q3	$3.82M	Sell	233,705 -56,295	-19%	-$1.13M	0.3%	76
2019 Q2	$5.31M	Buy	+290,000	New	+$4.6M	0.39%	77
2019 Q1	–	Sell	-444,347	Closed	-$4.9M	–	128
2018 Q4	$4.9M	Buy	+444,347	New	+$4.83M	0.42%	73

Other funds holding CYRX

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Friess Associates's CYRX Position: Q1 2022 in Review

Friess Associates sold out of CryoPort (CYRX) in Q1 2022, closing a stake of 105,044 shares — an estimated $6.21M sold.

Friess Associates first reported a position in CYRX in Q4 2018 and held it in 12 quarters. The position peaked at $7.55M in Q2 2021. 200 funds tracked by Wall St. Rank hold CYRX as of Q1 2022.

Friess Associates reported no remaining CryoPort position as of Q1 2022 after selling out during the quarter.
Friess Associates sold 105,044 CryoPort shares in Q1 2022, an estimated $6.21M.
Friess Associates first reported a position in CryoPort in Q4 2018 and held it in 12 quarters.
Friess Associates's CryoPort position peaked at $7.55M in Q2 2021.
200 funds tracked by Wall St. Rank held CryoPort as of Q1 2022.

Based on Friess Associates's 13F filing for Q1 2022, filed 12 May 2022.